An Oral Small Molecule VEGFR2 Inhibitor, Apatinib, in Patients with Recurrent or Refractory Cervical Cancer: A Real World Study

To evaluate the efficacy and safety of apatinib, an oral antiangiogenic drug, in patients with recurrent or refractory cervical cancer as salvage treatment, we retrospectively analyzed the medical records of recurrent or refractory cervical cancer patients admitted to the National Cancer Center/Canc...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Oncol
Autori principali: Li, Ning, Wang, Ziyi, Yuan, Guangwen, Sun, Yangchun, Zhang, Rong, Li, Xiaoguang, Li, Nan, Wang, Jing, Wu, Lingying
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi 2020
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7327550/
https://ncbi.nlm.nih.gov/pubmed/32655637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/3852373
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi